2017 Results March 1st, 2018 - Essilor International
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
2017 Key Highlights Good sales performance despite challenging optical market conditions Solid growth in the Lens & Equipment businesses Strong online sales Acceleration in the US in H2 Investments in China and e-commerce Full benefit of the French tax refund reinvested in fueling our Mission initiatives Record Free Cash Flow generation supported de-leveraging (1) Key steps toward the proposed combination with Luxottica (1) Free Cash Flow = Net cash from operating activities less change in WCR and capital expenditure. See slide 15. 2017 Results 2. 2017 Results 4
2017 Key Figures 2016 Growth 2017 +5.3% Revenue €7,115m €7,490m +3.5% Adjusted Contribution from operations(1)(2) €1,321m €1,367m As a percentage of revenue 18.6% 18.3% +1.6% Adjusted Earnings per share (2) €3.79 €3.85 +4.0% Adjusted Free Cash Flow(3) €963m €1,002m Dividend per share(4) €1.50 €1.53 (1) Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs and other operating expenses). (2) The 2017 accounts are adjusted for non-recurring items related, on one hand, to expenses associated with the proposed combination with Luxottica and, on the other hand, to the positive effects of tax changes in the United States and France. 2016 results are not adjusted. (3) Net cash from operating activities less change in WCR and capital expenditure. Adjusted for non-recurring items related to the German competition authority (BKA) in 2016 and to 2017 items including costs linked to the proposed transaction with Luxottica along with the settlement of litigation.. (4) To be submitted for shareholder approval at the April 24, 2018 Annual General Meeting. 2017 Results 2. 2017 Results 5
2017 Revenue Up 6.7% Excluding the Currency Effect € millions (103) 254 -1.4% +3.6% 224 +3.1% 7,490 +5.3% +6.7% 7,115 2016 Revenue Like-for-like Bolt-on Currency effect 2017 Revenue growth acquisitions (1) (1) Local acquisitions or partnerships. 2017 Results 2. 2017 Results 6
2017 Revenue by Division Change Reported revenue in € millions Lenses: solid momentum driven 2017 2016 At constant Like-for-like exchange rates Reported by new products and e- commerce Lenses & Optical Instruments 6,498 6,218 +3.4% +5.8% +4.5% Sunglasses & Readers 766 685 +0.1% +15.0% +12.0% Continued build-up in Equipment 226 212 +5.8% +7.8% +6.4% Sunglasses & Readers TOTAL 7,490 7,115 +3.1% +6.7% +5.3% Equipment and Instruments performed well Fast-Growing Countries(1) 1,825 1,641 +4.2% +12.0% +11.2% Developed Countries 5,665 5,474 +2.8% +5.1% +3.5% Fast-Growing Markets(1): 24% of total sales (1) Fast-growing countries include China, India, ASEAN, South Korea, Hong Kong, Taiwan, Africa, the Middle East, Russia and Latin America. All divisions combined. 2017 Results 2. 2017 Results 7
H2 2017 Like-for-like Revenue Growth: +3.8% Lik e-for-lik e revenue growth 2017 H1 2017 H2 2017 Lenses & Optical Instruments +3.4% +2.7% +4.1% Sharp acceleration in the US North America +4.1% +2.7% +5.5% Robust performance in China Europe +2.4% +2.1% +2.7% Asia/Pacific/Middle East/Africa +5.1% +5.0% +5.2% Strong online sales Latin America -0.9% -1.5% -0.4% FGX, Costa and MJS driving Sunglasses & Readers +0.1% -1.5% +1.9% improvement in Sunglasses & Readers Equipment +5.8% +11.7% +1.2% TOTAL +3.1% +2.5% +3.8% 2017 Results 2. 2017 Results 8
9 Acquisitions Representing ~€87m in Full-Year Revenue North America Europe 2 2 Topcon Visioncare Optitrade Japan Logistics Center Partners In Vision Vision Associates CFE Optique Latin America Opticas 2 Mangalsons Exclusivas Sun Optical Technologies Visolab Asia/Pacific/ 2 new countries: Middle East/Africa Ethiopia, Guatemala 3 2017 Results 2. 2017 Results 9
Reconciliation of Adjusted to Reported Accounts 2017 2017 2016 € millions Items adjusted Adjusted Reported Reported Revenue 7,490 7,490 7,115 Contribution from operations (1) 1,367 (6) 1,361 1,321 Other income (expense) (119) (168) (287) (91) Operating profit 1,248 (174) 1,074 1,230 Income tax (262) 131 (132) (285) Net profit 922 (44) 878 880 Net profit attributable to equity holders 833 (44) 789 813 of Essilor International Earnings per share 3.85 3.64 3.79 There are two main types of adjustment items. First, expenses associated with the proposed combination with Luxottica, and, second, the positive effects of tax changes in the United States and France. These non-recurring adjustments include: • Transaction costs related to the proposed combination with Luxottica for €109 million; • An additional cost of €45 million principally linked to the lifting of performance conditions on two employee shareholding plans • A one-time contribution for €19 million to mission-related activities focused on eradicating poor vision worldwide; • An exceptional gain from the refund of the 3% dividend tax in France, net of the additional tax, for €19 million; • A one-time gain linked to tax reform passed in the United States in December 2017 for €73 million. (1) Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs, other operating expenses). 2017 Results 2. 2017 Results 10
Adjusted Contribution from Operations (1) (2) up 3.5% 2017 2016 € millions Change Adjusted(2) Reported Revenue 7,490 7,115 +5.3% 4,346 E-commerce Gross profit 4,181 +3.9% A A Transitions sales % of revenue 58.0% 58.8% to other lens casters Operating expenses (2,979) (2,860) +4.2% % of revenue B 39.8% 40.2% B Opex management Contribution from operations (1) 1,367 1,321 +3.5% % of revenue 18.3% 18.6% (1) Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs, other operating expenses). (2) The 2017 accounts are adjusted for non-recurring items related, on one hand, to expenses associated with the proposed combination with Luxottica and, on the other hand, to the positive effects of tax changes in the United States and France. 2017 Results 2. 2017 Results 11
Adjusted Contribution from Operations (1) (2) at 18.3% of Revenue Contribution from operations as a percentage of revenue +0.3% -0.4% -0.2% Operational Transitions sales efficiencies to other lens New products: casters Varilux® X Brazil and India 18.6% series™, Strengthening the Eyezen™ 18.5% organization in E-commerce 18.3% China and improvement in e-commerce developed activities countries 2016 Reported Operating Leverage Other 2017 Adjusted (2) Acquisitions 2017 Adjusted (2) before acquisitions (1) Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs, other operating expenses). (2) The 2017 accounts are adjusted for non-recurring items related, on one hand, to expenses associated with the planned combination with Luxottica and, on the other hand, to the positive effects of tax changes in the United States and France. The reported accounts and a reconciliation of the reported accounts to the adjusted accounts are provided in appendices. 2017 Results 2. 2017 Results 12
Adjusted Net Profit Up 4.8% (2) 2017 2016 € millions Change Adjusted(2) Reported Revenue 7,490 7,115 +5.3% Contribution from operations (1) 1,367 1,321 +3.5% Share based payments Other income (expenses), net A (119) (91) - A Litigations’ provisions Transformation costs Operating profit 1,248 1,230 +1.5% Financial income (expense), net (64) (66) - Income tax (262) (285) - Effective tax rate B 22.1% 24.5% - B Advanced Pricing Agreement Net profit 922 880 +4.8% Minority interests C (89) (67) - Photosynthesis Group C Profit attributable to equity holders 833 813 +2.5% Partners’ performances Earnings per share (in €) 3.85 3.79 +1.6% (1) Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs, other operating expenses). (2) The 2017 accounts are adjusted for non-recurring items related, on one hand, to expenses associated with the proposed combination with Luxottica and, on the other hand, to the positive effects of tax changes in the United States and France. 2017 Results 2. 2017 Results 13
Capital Expenditure: Deploying Advanced Technologies to Support Long-term Growth 7% 6% 285 232 321 5% 192 5.6% 4.7% 227 4.8% New photochromic lens 4.6% 273 282 4% manufacturing lines 4.0% 3.8% 3.8% Modernization of regional 3% laboratories 2% 2011 2012 2013 2014 2015 2016 2017 XX = Capital expenditure in € million (net of disposals) Capital expenditure as a percentage of revenue 2017 Results 2. 2017 Results 14
Adjusted Free Cash Flow >€1bn (3) 58 Change in WCR € millions Fast De-leveraging Net debt in € millions 308 Capital expenditure 2,089 2,062 364 Dividends 1,793 Operating cash flow 1,661 1,291 (excl. change in WCR) +925 317 Net financial investments 400 Reported change in net debt Capital increase 34 Foreign exchange and others(2) 122 2014 2015 2016 2017 (1) Free cash flow = Net cash from operating activities less change in WCR and capital expenditure / (2) Including €96m of foreign exchange impact. / (3) Adjusted for non-recurring items related to the German competition authority (BKA) in 2016 and to 2017 items including costs linked to the proposed combination with Luxottica along with the settlement of litigation. 2017 Results 2. 2017 Results 15
Proposed Dividend(a) per Share 1.50 1.53 1.11 1.02 0.94 0.85 0.88 0.83 323 333 237 198 216 172 177 185 2010 2011 2012 2013 2014 2015 2016 2017 Payout (in € million) Dividend per share (in €) (a) To be submitted for shareholder approval at the April 24, 2018 Annual General Meeting. 2017 Results 2. 2017 Results 16
3. Essilor in 2018 Paul du Saillant – Chief Operating Officer Laurent Vacherot – President and Chief Operating Officer 2017 Results 17
Successful New Product Launches in 2017… Innovation USA FGM Online China Myopia North America Europe H2 H1 H2 Style Colours H1 collection 0 H2 Asia/Pacific Latin America H1 H1 2017 Results 3. Essilor in 2018 18
…Delivering Promising Results Innovation USA FGM Online China Myopia Above sales target Already 20% of Crizal® Eyezen™ volume Eye Protect System™, the ~70% of Varilux® volumes in the USA doubled in 2017 fastest growth in the blue series volumes Clear brand growth Broadened product filter lens category Trade up driver range Volume tripled in 2017 2017 Results 3. Essilor in 2018 19
Ongoing Benefits of Innovations in 2018 Innovation USA FGM Online China Myopia North America Europe NEW IN 2018 NEW IN 2018 Style Colours collection ONGOING BENEFIT ONGOING BENEFIT Asia Pacific Latin America NEW IN 2018 NEW IN 2018 2017 Results 3. Essilor in 2018 20
The “Ultimate Lens Package” Driving Strong Momentum in the US Innovation USA FGM Online China Myopia The Best in Vision, Clarity, and Protection in a Single Lens Single Vision Lens Wearers Progressive Lens Wearers [c.100 million people in the US] [c.52 million people in the US] + + + + Varilux®, Crizal® and Transitions® growing high single digit in Q4 2017 Source: Essilor - 2017 estimates 2017 Results 3. Essilor in 2018 21
Continuing Strong Key Account Partnerships Innovation USA FGM Online China Myopia Category development Supply chain offering New partnerships formed Faster growing retail groups Interest from new players 2017 Results 3. Essilor in 2018 22
Fast-Growing Markets Will Continue to Drive Growth (1) Innovation USA FGM Online China Myopia Africa-Middle East Asia-Pacific Latin America NEW NEW Ethiopia Indonesia Vietnam Guatemala >100m inhabitants 260m inhabitants 100m inhabitants Acquisition of an integrated Partnership with market leader Expansion to 35 cities New prescription laboratory prescription laboratory with Joint approach by business Mid-tier acceleration >100 accounts trained in 2017 ~50 optical stores and mission 1,500 Mitra Mata by end 2018 88 Vision Ambassadors 2017 revenue growth > 15% (like-for-like and bolt-on acquisitions combined, including Lenses and Optical Instruments, Equipment and Sunglasses & Readers) 2017 revenue growth < 15% (like-for-like and bolt-on acquisitions combined, including Lenses and Optical Instruments, Equipment and Sunglasses & Readers) (1) Fast-growing markets include China, India, ASEAN, South Korea, Hong Kong, Taiwan, Africa, the Middle East, Russia and Latin America 2017 Results 3. Essilor in 2018 23
E-Commerce Ready to Sustain High Growth Innovation USA FGM Online China Myopia En Route to €500m Revenue Stronger Foundation for Future Growth Key 2017 achievements: €440m(1) (2) +39% vs. prior year Global organization fully established +15% like-for-like growth Strong growth from mature markets €325m(1) (2) Increased our presence in FGM +47% vs. prior year RoW Strategic giving programs North America Key areas of focus for 2018 onwards Accelerate in the eyeglass segment Europe Develop platforms for key Sun brands 2016 2017 Increased focus on proprietary contact lens brands (1) Including Sunglasses & Readers online sales Leveraging digital properties (2) At constant exchange rates 2017 Results 3. Essilor in 2018 24
Delivering 30% Revenue Growth in China in 2017 Innovation USA FGM Online China Myopia Retail and Online Double digit growth Lens Business Double digit growth MJS/Aojo deployment Eyezen™ Growing presence on leading Kodak®/Partners platforms Creasky New retail Quality Wholesalers Over 1,200 stores 2018 Revenue >€500m Sunwear Bolon™ streamlined supply chain, strong brand equity International deployment Mujosh brand 2017 China Revenue Breakdown 2017 Results 3. Essilor in 2018 25
A New Consumer-Driven Organization Innovation USA FGM Online China Myopia AFFORDABLE INCLUSIVE LENSES MYOPIA SOLUTIONS SUNWEAR & FASHION SOLUTIONS KEY ACCOUNT ORGANIZATION Myopia Management 2.5 New Vision ONLINE ORGANIZATION Kids & Teens €5.8bn Generation Essilor Vision Foundation Distribution of MONOBRAND specialized Last mile RETAIL products distribution WHOLESALE 800 million consumers in need of vision care; 4 people out of 10 are myopic Unique leadership and management team 2017 Results 3. Essilor in 2018 26
Innovate in the Myopia Segment: A 5 Bn Wearer Opportunity Innovation USA FGM Online China Myopia A Growing Pandemic Key Consumer Challenges 2017 CAGR 2030 CAGR 2050 Poor aesthetics and physical comfort Billion people(1) 5.0 Growing prevalence of myopia in children(2) 3.1% 2.7 Risk of eye disease in high myopes(3) 3.2% 1.8 A Dedicated Organization Integrated approach including science, awareness, solutions and distribution Global team reporting to COO Dedicated business unit in China (1) Source: Essilor estimates, Brien Holden Vision Institute (2) Morgan IG1, Ohno-Matsui K, Saw SM. Myopia. Lancet. 5 May 2012 (3) Verkicharla, Ohno-Matsui, Saw. Current and predicted demographics of high myopia and an update of its associated pathological changes, Ophtalmologic & Physiological Optics. 2015 2017 Results 3. Essilor in 2018 27
Further Progress towards our Core Ambition: Eradicating Poor Vision Within One Generation in billions of people 12 # Uncorrected in billion of people 10 3.8 8 3.3 $5 3.3 to improve the sight of one person* 6 2.5 2.6 2.5 4 2.0 2 2.9 3.8 Collective impact $500M / yr 0 to eradicate poor vision 0 in 30+ years 2017 2050 2017 2050 2100 No need for vision correction Corrected If we do nothing Impact with $500M/yr Uncorrected (*) Low-income populations and people living below the international poverty line 2017 Results 3. Essilor in 2018 28
Accelerating in 2018 Awareness Inclusive Business Strategic Giving More than 5,700 primary Essilor Social Impact Fund vision care providers trained in ten countries at the end of 2017 More than 3,000 Essilor New countries: Bangladesh, employees volunteered Liberia, Indonesia globally Private Public Partnerships Product Innovation €19 million new contribution 2017 Results 3. Essilor in 2018 29
Essilor in 2018 at a Glance Deployment of robust innovation pipeline Lenses business Strong potential in the US and China Improvement in Brazil and India Sustained momentum in developed countries E-commerce Continue to invest in fast-growing markets Sunglasses Xiamen Yarui Optical (Bolon™) expected to be back to growth & Readers Expansion of MJS and Aojo footprint Targeting acceleration from acquisitions & partnerships in H2 Group-wide Tax rate similar to 2017 level Continued deleveraging 2017 Results 3. Essilor in 2018 30
Outlook for 2018 Like-for-like Revenue Growth Around 4% Contribution from operations(1) as a percentage of revenue ≥ 18.3%(2) Finalization of the Essilor and Luxottica proposed combination planned for the first part of 2018 (1) Contribution from operations = Revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs, other operating expenses). (2) Excluding any new strategic acquisition(s). 2017 Results 3. Essilor in 2018 31
Questions & Answers
4. Appendices 2017 Results 33
Reported P&L Statement € millions 2017 2016 Change Revenue 7,490 7,115 +5.3% Gross profit 4,346 4,181 +3.9% % of revenue 58.0% 58.8% Contribution from operations (1) 1,361 1,321 +3.0% % of revenue 18.2% 18.6% Operating profit 1,074 1,230 -12.7% Net profit 878 880 -0.1% Net profit attributable to equity holders 789 813 -3.0% of Essilor International % of revenue 10.5% 11.4% Earnings per share (in €) 3.64 3.79 -4.0% (1) Contribution from operations corresponds to revenue less cost of sales and operating expenses (research and development costs, selling and distribution costs, other operating expenses). 2017 Results 4. Appendices 34
You can also read